Table 4.

Combined diagnoses and procedural related complications reported 3, 6, and 12 months after cryotherapy in men diagnosed with incident localized prostate cancer and no prior history of treatment related morbidity, SEER-Medicare.

	3 months		6 months		12 months
Complication	n	%	n	%	n	%
1Lower Urinary Tract Obstruction	78	23.7	90	27.4	94	28.7
2Erectile Dysfunction	14	4	46	13.2	70	20.1
3Urinary Incontinence	14	3.8	29	7.9	36	9.8
4Bowel Bleeding	<11	<2.9	<11	<2.9	12	3.3
5Hydronephrosis	0	0	0	0	0	0
6Urinary Fistula	0	0	0	0	0	0
7Bowel Fistula	0	0	0	0	0	0

¹Lower Urinary Tract Obstruction included medical claim of dilation, urethrotomy, urethroplasty, sphincterotomy; transurethral prostate resection/destruction; urethral stent; or injection for stricture occuring. 328 men had no prior history of urinary obstruction prior to cryotherapy.

²Erectile Dysfunction included medical claim for penile prosthesis or intracavernosal. 349 men had no Prior history of erectile dysfunction prior to cryotherapy.

³Urinary incontinence included a medical claim of urethra sphincter injection, artificial sphincter, or incontinence repair (sling, urethroplasty) occuring. 368 men had no prior history of urinary incontinence prior to cryotherapy.

⁴Bowel bleeding included hemorrhage or inflammation. 359 men did not have bowel bleeding prior to cryotherapy.

⁵Hydronephrosis is distention of the renal pelvic and calices of the kidney with urine.

⁶Bowel Fistula included medical claims of rectal repair, colostomy or ulcer.

⁷Urinary Fistula was defined as medical claims with repair of bowel-bladder fistula or closure of urethrostomy or urethrocutaneous fistula occurring.